Total Payments
$16,787
2024 Payments
$5,135
Companies
21
Transactions
859
Medicare Patients
235
Medicare Billing
$31,496
Payment Breakdown by Category
Food & Beverage$13,129 (78.2%)
Other$3,275 (19.5%)
Education$383.01 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,129 | 845 | 78.2% |
| Debt forgiveness | $3,275 | 5 | 19.5% |
| Education | $383.01 | 9 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $3,611 | 178 | $0 (2024) |
| Neuronetics, Inc. | $3,304 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,449 | 181 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,174 | 155 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,076 | 46 | $0 (2024) |
| Lundbeck LLC | $1,018 | 62 | $0 (2024) |
| ITI, Inc. | $759.85 | 54 | $0 (2023) |
| Indivior Inc. | $713.76 | 44 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $690.02 | 23 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $509.72 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,135 | 100 | Neuronetics, Inc. ($3,275) |
| 2023 | $1,701 | 84 | Alkermes, Inc. ($606.90) |
| 2022 | $1,490 | 96 | Alkermes, Inc. ($449.43) |
| 2021 | $1,947 | 132 | Alkermes, Inc. ($556.14) |
| 2020 | $1,509 | 105 | Allergan, Inc. ($243.49) |
| 2019 | $1,604 | 115 | Alkermes, Inc. ($373.63) |
| 2018 | $2,114 | 145 | Otsuka America Pharmaceutical, Inc. ($493.08) |
| 2017 | $1,288 | 82 | Alkermes, Inc. ($376.80) |
All Payment Transactions
859 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: CNS | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: CNS | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: CNS | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $28.18 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $875.00 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 11/14/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $875.00 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 11/14/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $875.00 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 11/14/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $325.00 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 11/14/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $325.00 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 11/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: CNS | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.79 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: CNS | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Neurology | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| 10/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: CNS | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 61 | 87 | $13,470 | $6,784 |
| 2022 | 2 | 60 | 99 | $15,300 | $8,022 |
| 2021 | 1 | 47 | 100 | $17,500 | $8,505 |
| 2020 | 1 | 67 | 173 | $22,490 | $8,186 |
Total Patients
235
Total Services
459
Medicare Billing
$31,496
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 48 | $8,400 | $4,153 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 39 | $5,070 | $2,631 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 54 | $9,450 | $4,884 | 51.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 45 | $5,850 | $3,138 | 53.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 100 | $17,500 | $8,505 | 48.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 173 | $22,490 | $8,186 | 36.4% |
About Dr. John Middleton, M.D
Dr. John Middleton, M.D is a Psychiatry healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427160720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Middleton, M.D has received a total of $16,787 in payments from pharmaceutical and medical device companies, with $5,135 received in 2024. These payments were reported across 859 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($13,129).
As a Medicare-enrolled provider, Middleton has provided services to 235 Medicare beneficiaries, totaling 459 services with total Medicare billing of $31,496. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Fresno, CA
- Active Since 08/31/2006
- Last Updated 11/13/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427160720
Products in Payments
- NEUROSTAR TMS THERAPY SYSTEM (Device) $3,275
- ARISTADA (Drug) $2,733
- REXULTI (Drug) $2,100
- TRINTELLIX (Drug) $993.96
- ABILIFY MAINTENA (Drug) $982.91
- INVEGA SUSTENNA (Drug) $928.66
- CAPLYTA (Drug) $923.98
- Aristada 441 mg (Drug) $700.87
- PERSERIS (Drug) $571.29
- VRAYLAR (Drug) $531.33
- LATUDA (Drug) $509.72
- Trintellix (Drug) $408.95
- AUSTEDO (Drug) $211.84
- NUEDEXTA (Drug) $178.00
- INGREZZA (Drug) $171.29
- UZEDY (Drug) $169.70
- ABILIFY ASIMTUFII (Drug) $167.59
- SUBLOCADE (Drug) $142.47
- INVOKANA (Drug) $108.32
- Vivitrol 380 mg (Drug) $105.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Fresno
Herbert Cruz, Md, MD
Psychiatry — Payments: $428,403
Psychiatry $428,403
Paul Markovitz, Md Phd, MD PHD
Psychiatry — Payments: $240,862
Psychiatry $240,862
Sukhjit Brar, M.d, M.D
Psychiatry — Payments: $194,762
Psychiatry $194,762
Dwight Sievert, M.d, M.D
Psychiatry — Payments: $24,855
Psychiatry $24,855
Dr. Edgar Castillo-Armas, M.d, M.D
Psychiatry — Payments: $22,645
Psychiatry $22,645
Dr. Kenneth Steinbach, M.d, M.D
Psychiatry — Payments: $15,499
Psychiatry $15,499